ACR/EULAR 2010 Rheumatoid Arthritis Classification Criteria
Why Use
Provides a standardized approach to diagnosing RA, allowing for prompt treatment with disease-modifying antirheumatic drugs (DMARDs).
When to Use
Use to evaluate suspected cases of rheumatoid arthritis (RA) in patients with inflammatory synovitis. Can be utilized in research or clinical trials to establish a uniform diagnostic standard for RA patients.
Formula
Pearls / Pitfalls
These criteria were created to emphasize RA characteristics, particularly those that emerge early in the disease course and are associated with erosive and/or persistent disease. Other inflammatory diseases, like gout, lupus, or psoriatic arthritis, may mimic RA, potentially leading to misclassification. Keep in mind, many individuals with RA may not satisfy these criteria, particularly very early on in the course of the disease.
Advice
This tool should be used as a guide in diagnosing RA alongside clinical judgment, diagnostics, and specialist consultation, particularly in borderline or atypical cases. Score ≥6 with synovitis in ≥1 joint and absence of an alternative diagnosis: Highly indicative of RA. Refer to a rheumatologist for further management and possible initiation of DMARD therapy. Regularly monitor disease activity and response to therapy. Score <6: Consider alternative diagnoses; further diagnostic workup (e.g., imaging, additional labs) may be warranted. Closely monitor and reassess if the patient’s symptoms change or evolve.
More Information
Interpretation: Score Diagnosis ≥6 Definite RA <6 Not classifiable as having RA by ACR/EULAR Criteria